Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Ko

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Translational Lung Cancer Research|February 2, 2019
Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC "capitulate"?Brian Ko, Balazs Halmos
Heart Asia|June 22, 2016
Saphenous vein coronary bypass graft aneurysm with fistula to right atrium demonstrated on dynamic-volume 320-slice computed tomographyBrian Ko, Andrew Cochrane, Sujith Seneviratne
Lung Cancer (Auckland, N.Z.)|October 27, 2017
<i>EGFR</i> T790M: revealing the secrets of a gatekeeperBrian Ko, Daniel Paucar, Balazs Halmos
Australian Journal of General Practice|August 3, 2020
Coronary artery calcium in primary preventionAlexander Chua, Ron Blankstein, Brian Ko
JACC. Cardiovascular Interventions|November 21, 2017
Assessment of Serial Coronary Stenoses With Noninvasive Computed Tomography-Derived Fractional Flow Reserve and Treatment Planning Using a Novel Virtual Stenting ApplicationAbdul Rahman Ihdayhid, Anthony White, Brian Ko
Heart, Lung & Circulation|July 18, 2020
CT-Derived Fractional Flow Reserve (CT-FFR) in the Evaluation of Coronary Artery DiseaseNancy Khav, Abdul Rahman Ihdayhid, Brian Ko
Cancer|October 4, 2025
Top advances of the year: Noninvasive colorectal cancer screening testsBrian Ko, Pakdee Rojanasopondist, William M Grady
Annals of Neurology|October 26, 2020
Cardiovascular Safety of Nilotinib in Alzheimer DiseaseSean Tan, Diva Baggio, Jake Shortt, et al.
Annals of Translational Medicine|February 7, 2017
MET/HGF pathway activation as a paradigm of resistance to targeted therapiesBrian Ko, Tianfang He, Shirish Gadgeel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 20, 2021
Cardiovascular Safety of Nilotinib in Parkinson's DiseaseSean Tan, Diva Baggio, Jake Shortt, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Translational Lung Cancer Research|February 2, 2019
Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC "capitulate"?Brian Ko, Balazs Halmos
Heart Asia|June 22, 2016
Saphenous vein coronary bypass graft aneurysm with fistula to right atrium demonstrated on dynamic-volume 320-slice computed tomographyBrian Ko, Andrew Cochrane, Sujith Seneviratne
Lung Cancer (Auckland, N.Z.)|October 27, 2017
<i>EGFR</i> T790M: revealing the secrets of a gatekeeperBrian Ko, Daniel Paucar, Balazs Halmos
Australian Journal of General Practice|August 3, 2020
Coronary artery calcium in primary preventionAlexander Chua, Ron Blankstein, Brian Ko
JACC. Cardiovascular Interventions|November 21, 2017
Assessment of Serial Coronary Stenoses With Noninvasive Computed Tomography-Derived Fractional Flow Reserve and Treatment Planning Using a Novel Virtual Stenting ApplicationAbdul Rahman Ihdayhid, Anthony White, Brian Ko
Heart, Lung & Circulation|July 18, 2020
CT-Derived Fractional Flow Reserve (CT-FFR) in the Evaluation of Coronary Artery DiseaseNancy Khav, Abdul Rahman Ihdayhid, Brian Ko
Cancer|October 4, 2025
Top advances of the year: Noninvasive colorectal cancer screening testsBrian Ko, Pakdee Rojanasopondist, William M Grady
Annals of Neurology|October 26, 2020
Cardiovascular Safety of Nilotinib in Alzheimer DiseaseSean Tan, Diva Baggio, Jake Shortt, et al.
Annals of Translational Medicine|February 7, 2017
MET/HGF pathway activation as a paradigm of resistance to targeted therapiesBrian Ko, Tianfang He, Shirish Gadgeel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 20, 2021
Cardiovascular Safety of Nilotinib in Parkinson's DiseaseSean Tan, Diva Baggio, Jake Shortt, et al.
Pageof 11